Skip to main content
European Commission logo
English English
CORDIS - EU research results
CORDIS
Content archived on 2024-05-24

Alpha-1 international registry

Objective

Alpha-1-antitrypsin deficiency (AAD) is a rare inherited disorder on chromosome 14q32.1 that predisposes to liver, vascular but especially early onset, rapidly progressive lung disease. As recommended by the WHO in 1996 in Geneva, we have established an international registry in January 1999 and developed a simple database and DNA bank, now containing over 300 European patients with AAD. The proposed Action is to execute a study using genome-wide linkage and association studies in DNA samples, to find other genetic risk factors explaining why some smokers with the inherited deficiency develop lung emphysema, while others with the same smoking history don’t. Furthermore, we aim to use existing European databases on air pollution to find correlations with clinical data and/or new genetic information in a two year longitudinal study with AAD patients. Funding is requested to enable the logistics around the two proposed studies.

Call for proposal

Data not available

Coordinator

UNIVERSITY OF BIRMINGHAM
EU contribution
No data
Address
Edgbaston
B15 2TH BIRMINGHAM
United Kingdom

See on map

Total cost
No data

Participants (9)